CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Indirect comparisons (ICs) of once weekly dulaglutide (DU) plus metformin (MET) versus sulphonylureas (SU) plus MET in patients with type 2 diabetes (T2D) from AWARD-5
DOI 10.1055/s-0035-1549664
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Baeumler, E Heitmann, C Nicolay, H Jung
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Objective: German “Gemeinsamer Bundesausschuss (G-BA)” determined SU+MET as a comparator for DU+MET. ICs examined the relative efficacy and safety of these regimens in adult patients with T2D. Methods: Randomised controlled trials (n = 3) were identified by systematic review for ICs with AWARD-5 data; Sitagliptin+MET was the bridging comparator. Eligibility criteria for this second-order IC (Bucher method) included:…
Zitieren
Zitierempfehlung
J Baeumler, E Heitmann, C Nicolay, H Jung (2015) Indirect comparisons (ICs) of once weekly dulaglutide (DU) plus metformin (MET) versus sulphonylureas (SU) plus MET in patients with type 2 diabetes (T2D) from AWARD-5. Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-0035-1549664
Mit CareLit weiterarbeiten